Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
about
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedinA Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaTrabectedin for advanced soft tissue sarcomas: optimizing useManagement Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinA comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin.Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasSafety evaluation of trabectedin in treatment of soft-tissue sarcomas.Trabectedin for the treatment of breast cancer.Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options.Trabectedin for the treatment of soft tissue sarcomas.Efficacy of trabectedin for the treatment of liposarcoma.Newer medical therapies for metastatic soft tissue sarcoma.Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860
Q26738346-FDD28A4B-8558-4C11-987C-B58C4739FAB6Q26741817-97A46A7E-E9C4-4646-923F-8510C338E975Q26860365-0609C483-9034-446F-B10A-54830A3CE829Q28087771-1550DB67-2B39-4D6A-96D5-D745507DB867Q35246995-C8765BFA-3F59-4850-BCCD-30DE91B64538Q35996144-46A4BE3C-A2D5-4D54-A5E7-8BED1014BD02Q37214309-32F7E505-9803-4A3A-ABC3-7C8361FF2615Q37669484-D2EA2132-5A70-4717-A1C2-980B58247FFFQ38128352-39D5B073-27CF-4C87-8B44-A2F022B21DC0Q38642314-CE96F0C9-F6DC-4938-ADCD-C7ADB20650F8Q38731757-DBBD756E-D694-4D6D-B081-6138B9D8D675Q38872192-B06AAB12-DE09-4809-82B0-3C6090DF0059Q38951318-9430DC96-8866-4548-A7EC-7165C8C46D3DQ39012067-E59A6F32-3538-4E90-BE68-1FD88F5D0A1EQ47144710-C60F686D-05D0-4DD1-9C04-F5CACC9C3FCDQ55365628-B1D13018-35BB-453C-9C6D-4EF1138EE962
P2860
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@ast
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@en
type
label
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@ast
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@en
prefLabel
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@ast
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@en
P2093
P2860
P1476
Trabectedin in pre-treated pat ...... -treatment with dexamethasone.
@en
P2093
Adnan Tanović
Andrés Poveda
Antonio Casado
Antonio López-Pousa
Antonio Nieto
Carmen Balañá
Fernando Rivera-Herrero
Hernán Cortes-Funes
Javier García del Muro
Joaquim Bellmunt
P2860
P2888
P304
P356
10.1007/S10637-010-9561-9
P577
2010-10-20T00:00:00Z
P6179
1041053254